TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,618,677 | -26.5% | 358,332 | +12.7% | 0.00% | -20.0% |
| Q2 2023 | $26,691,700 | +258.8% | 317,834 | +223.6% | 0.01% | +150.0% |
| Q1 2023 | $7,438,125 | -1.4% | 98,219 | -19.6% | 0.00% | 0.0% |
| Q4 2022 | $7,540,702 | +4.5% | 122,176 | -29.3% | 0.00% | 0.0% |
| Q3 2022 | $7,218,000 | +496.5% | 172,908 | +349.5% | 0.00% | – |
| Q2 2022 | $1,210,000 | +71.6% | 38,466 | +46.9% | 0.00% | – |
| Q1 2022 | $705,000 | +138.2% | 26,179 | +69.6% | 0.00% | – |
| Q4 2021 | $296,000 | -56.9% | 15,439 | -25.5% | 0.00% | – |
| Q3 2021 | $686,000 | -18.5% | 20,717 | -18.3% | 0.00% | – |
| Q2 2021 | $842,000 | -41.8% | 25,367 | -27.3% | 0.00% | – |
| Q1 2021 | $1,447,000 | +502.9% | 34,869 | +188.7% | 0.00% | – |
| Q4 2020 | $240,000 | +36.4% | 12,077 | -5.6% | 0.00% | – |
| Q3 2020 | $176,000 | -41.7% | 12,799 | -24.2% | 0.00% | – |
| Q2 2020 | $302,000 | +69.7% | 16,879 | +14.6% | 0.00% | – |
| Q1 2020 | $178,000 | – | 14,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
| Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
| Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
| EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
| RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
| NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
| ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
| Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |